TrialEuropean radiology experimental2024

Amide proton transfer-weighted CEST MRI for radiotherapy target delineation of glioblastoma: a prospective pilot study.

Patrick L Y Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.